Core-shell Nanofibers with Tunable Dimensions and Mechanics for Targeting Immune Cells in the Intestine – Fitt-In
Oral vaccination offers great potential since it does not require trained personal, avoids the use of needles, and improves compliance of patient. However, vaccination through mucosal routes remains a great challenge. It suffers from low efficiency because the antigens face several severe hurdles by the mucosal barrier before they reach the target immune cells located in the mucosa-associated lymphoid tissues (MALT). Therefore, the objective of the Fitt-In project is to synthesize polymeric core-shell nanoparticles (NP) with controlled dimensions and tunable mechanical properties, conjugated with specific intestinal M cells- and immunocytes-targeting peptide-ligands that should facilitate the transport of the NP through intestinal M cells and their further interaction with the immune cells in MALT. Together, understanding the role of NP dimensions and the mechanics of specific ligands-conjugated NP, and thereby modulation in their interactions with the mucosal immune system should lay the path towards more efficient oral vaccination.
Project coordination
Jutta Rieger (Institut Parisien de Chimie Moléculaire)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partnership
IRCP Institut de Recherche de Chimie Paris
IPCM Institut Parisien de Chimie Moléculaire
IP - Département de Mycologie Institut Pasteur
IGPS Institut Galien Paris-Saclay
Help of the ANR 574,384 euros
Beginning and duration of the scientific project:
February 2024
- 48 Months